Title X funding block affects clinics that help with abortion and Planned Parenthood, making it more difficult for the less ...
(Plexium), a leading next-generation targeted protein degradation company, today announced that initial Phase 1 clinical results with PLX-4545, a selective IKZF2 molecular glue degrader, and ...
The discovery and preclinical efficacy of ANS-858, a proprietary, selective, reversible, orally bioavailable ALDH2 inhibitor�will be presented at 48th Annual Scientific Meeting of the Research Society ...
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel B7-H3-targeting ADC (R&D code: 7MW3711) has been approved by the NMPA ...
Today, miraDry, Inc., in partnership with the International Hyperhidrosis Society (IHhS), announced the results of a landmark study focusing on a rarely discussed aspect of menopause: underarm sweat ...
The global Traditional Wound Care Market , valued at US$7.15 billion in 2024, is forecasted to grow at a robust CAGR of 4.2%, reaching US$7.42 billion in 2025 and an impressive US$9.12 billion by 2030 ...
Understood.org, a leading resource for people with learning and thinking differences, today announced the launch of Climbing the Walls, a new limited-series investigative podcast. Hosted by health and ...
Exposed Children will make its debut as a featured supporter at the 2025 Rx and Illicit Drug Summit, the nation's premier gathering ...
The National Pediatric Cancer Foundation ( ) (NPCF) is proud to announce the launch of its latest campaign, the " 43 Challenge ( ) ," aimed at raising awareness and funds to support the fight ...
The National Comprehensive Cancer Network� (NCCN�)�an alliance of leading cancer centers�celebrated 30 years of helping peop ...
With food prices rising, families are embracing a playful, budget-friendly tradition� Easter potatoes! "Kids of all ages love that potatoes offer an easy, fun, and affordable way to get creative," ...
PR Newswire SAN RAFAEL, Calif., April 2, 2025 Company plans to submit for regulatory approval later this year SAN RAFAEL, Calif., April 2, 2025 /PRNewswire/ -- BioMarin Pharmaceut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results